Drug Description in Trials / DrugBank / KEGG DRUG
Search results
No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
---|---|---|---|---|---|---|
1 | 100 mg LX3305 QD | - | - | - | - | [1] 46 46 |
2 | 150 mg LX3305 QD | - | - | - | - | [1] 46 46 |
3 | 200 mg LX3305 QD | - | - | - | - | [1] 46 46 |
4 | 250 mg LX3305 BID | - | - | - | - | [1] 46 46 |
5 | 250 mg LX3305 QD | - | - | - | - | [1] 46 46 |
6 | 300 mg LX3305 QD | - | - | - | - | [1] 46 46 |
7 | 400 mg LX3305 QD | - | - | - | - | [1] 46 46 |
8 | 50 mg LX3305 QD | - | - | - | - | [1] 46 46 |
9 | 500 mg LX3305 QD | - | - | - | - | [1] 46 46 |
10 | LX3305 | - | - | - | - | [2] 46 46, 161 |
11 | LX3305 250 mg capsule | - | - | - | - | [1] 161 161 |
12 | LX3305 Dihydrate | - | - | - | - | [1] 46 46 |
13 | LX3305 high dose | - | - | - | - | [1] 46 46 |
14 | LX3305 low dose | - | - | - | - | [1] 46 46 |
15 | LX3305 mid dose | - | - | - | - | [1] 46 46 |